Search

everythinglearnresearchcommunity

for

Search:↓

SSEA-4 can distinguish between eccrine and apocrine sweat gland ducts.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Vitamin D might help treat alopecia areata.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

A bull got very sick and had to be put down after eating hairy vetch for months.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

The document explains various skin conditions and their treatments.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

Tinea capitis can rarely cause urticarial skin reactions in children.

Some people have severe allergic reactions to anthelminthic drugs, but these are often due to the parasites, not the drugs.

Large prostate patients more likely to have hair loss.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.